Starpharma Pauses UK Sales Of COVID Nasal Spray

Starphama has paused sales of its antiviral COVID-19 nasal spray following correspondence with the UK medicines regulator “in relation to specific promotional claims made for Viraleze, including references to SARS-CoV-2 and COVID-19, and the interrelationship between these product claims and its categorization,” according to the firm.